Eric B. Haura

IPEP: an in silico tool to examine proteolytic peptides for mass spectrometry

Steven Eschrich, Victoria Izumi, John Koomen, 2008, Bioinform..

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma

Bin Fang, Keiryn L. Bennett, John M. Koomen, 2015, PloS one.

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

William Pao, John D. Minna, Yu Shyr, 2014, JAMA.

Proteomic Contributions to Personalized Cancer Care*

Timothy J. Yeatman, John M. Koomen, Rebecca Sutphen, 2008, Molecular & Cellular Proteomics.

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

William S. Bush, Bin Zhu, Angeline S. Andrew, 2017, Nature Genetics.

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer

Bin Fang, Steven Eschrich, Giulio Superti-Furga, 2010, Nature chemical biology.

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma

Steven Eschrich, Dung-Tsa Chen, William J. Fulp, 2015, Oncogene.

Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells

Bin Fang, John M. Koomen, Steven A. Eschrich, 2013, Proceedings of the National Academy of Sciences.